Search

hUCB Plasma Therapeutic for Neurodegenerative Diseases

The USPTO granted patent US12605409B1 to the University of South Florida covering a method of treating neurodegenerative diseases using plasma derived from human umbilical cord blood (hUCB plasma). The patent discloses that hUCB plasma attenuated hyperactive mitogen responses and reduced caspase 3/7 activity in ALS patient cells, supporting therapeutic efficacy. Assignee: University of South Florida; inventors: Svitlana Garbuzova-Davis, Jared Carl Ehrhart, and Paul R. Sanberg.